Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation

References

• Guo D, Yin X, Wu D, Chen J, Ye X. Natural polysaccharides from Glycyrrhiza uralensis residues with typical glucan structure showing inhibition on α-glucosidase activities. Int J Biol Macromol. 2023; 224:776–785.
   PubMed Web of Science ®Google Scholar
• van Dinteren S, Meijerink J, Witkamp R, van Ieperen B, Vincken J-P, Araya-Cloutier C. Valorisation of liquorice (Glycyrrhiza) roots: antimicrobial activity and cytotoxicity of prenylated (iso)flavonoids and chalcones from liquorice spent (G. glabra, G. inflata, and G. uralensis). Food Funct. 2022;13(23):12105–12120.
   PubMed Web of Science ®Google Scholar
• Qiao X, Ji S, Yu S-w, Lin X-h, Jin H-w, Duan Y-k, Zhang L-r, Guo D-a, Ye M. Identification of key licorice constituents which interact with cytochrome P450: Evaluation by LC/MS/MS cocktail assay and metabolic profiling. Aaps J. 2014;16(1):101–113.
   PubMed Web of Science ®Google Scholar
• Muthu SA, Sharma R, Qureshi A, Parvez S, Ahmad B. Mechanistic insights into monomer level prevention of amyloid aggregation of lysozyme by glycyrrhizic acid. Int J Biol Macromol. 2023;227:884–895.
   PubMed Web of Science ®Google Scholar
• Langer D, Mlynarczyk DT, Dlugaszewska J, Tykarska E. Potential of glycyrrhizic and glycyrrhetinic acids against influenza type A and B viruses: a perspective to develop new anti-influenza compounds and drug delivery systems. Eur J Med Chem. 2023;246:114934.
   PubMed Web of Science ®Google Scholar
• Lee HE, Yang G, Han S-H, Lee J-H, An T-J, Jang J-K, Lee JY. Anti-obesity potential of Glycyrrhiza uralensis and licochalcone A through induction of adipocyte browning. Biochem Biophys Res Commun. 2018;503(3):2117–2123.
   PubMed Web of Science ®Google Scholar
• Li K, Ji S, Song W, Kuang Y, Lin Y, Tang S, Cui Z, Qiao X, Yu S, Ye M. Glycybridins A − K, bioactive phenolic compounds from Glycyrrhiza glabra. J Nat Prod. 2017;80(2):334–346.
   PubMed Web of Science ®Google Scholar
• Keretsu S, Bhujbal SP, Cho SJ. Rational approach toward COVID‑19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation. Sci Rep. 2020;10(1):17716.
   PubMed Web of Science ®Google Scholar
• World Health Organization, Coronavirus disease (COVID-19). https://www.who.int/health - topics/coronavirus#tab=tab_1. (acessed data: 10 March 2023.
   Google Scholar
• Eberle RJ, Olivier DS, Amaral MS, Gering I, Willbold D, Arni RK, Coronado MA. The repurposed drugs suramin and quinacrine cooperatively inhibit SARS-CoV-2 3CLpro in vitro. Viruses. 2021;13:873.
   PubMed Web of Science ®Google Scholar
• Citarella A, Scala A, Piperno A, Micale N. SARS-CoV Mpro: a potential target for peptidominetics and small-molecule inhibitors. Biomolecules. 2021;11:607.
   PubMed Web of Science ®Google Scholar
• Xia Z, Sacco M, Hu Y, Ma C, Meng X, Zhang F, Szeto T, Xiang Y, Chen Y, Wang J. Rational design of hybrid SARS-CoV-2 main protease inhibitors guided by the superimposed cocrystal structures with the peptidomimetic inhibitors GC-376, Telaprevir, and Boceprevir. ACS Pharmacol Transl Sci. 2021;4(4):1408–1421.
   PubMedGoogle Scholar
• Melo-Filho CC, Bobrowski T, Martin H-J, Sessions Z, Popov KI, Moorman NJ, Baric RS, Muratov EN, Tropsha A. Conserved coronavirus proteins as target of broad-spectrum antivirals. Antiviral Res. 2022;204:105360.
   PubMed Web of Science ®Google Scholar
• V’kovski P, Kratzel A, Steiner S, Stalder Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev. 2021;19:155–170.
   Google Scholar
• Nand M, Maiti P, Joshi T, Chandra S, Pande V, Kuniyal JC, Ramakrishnan MA. Virtual screening of anti‑HIV1 compounds against SARS‑CoV‑2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis. Sci Rep. 2020;10(1):20397.
   PubMed Web of Science ®Google Scholar
• Park Y-I, Kim JH, Lee S, Lee IS, Park J. Eupatin, a flavonoid, inhibits coronavirus 3CL protease and replication. Inter J Mol Sci. 2023;24:9221.
   PubMed Web of Science ®Google Scholar
• Kim JH, Park Y-I, Hur M, Park WT, Moon Y-H, Koo SC, Her Y-C, Lee IS, Park J. The inhibitory activity of methoxyl flavonoids derived from Inula britannica flowers on SARS-CoV-2 3CLpro. Int J Biol Macromol. 2022;222(Pt B):2098–2104.
   PubMedGoogle Scholar
• Jo S, Kim S, Kim DY, Kim M-S, Shin DH. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J Enzyme Inhib Med Chem. 2020;35(1):1539–1544.
   PubMed Web of Science ®Google Scholar
• Kim JH, Park JS, Lee YJ, Choi S, Kim YH, Yang SY. Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of Ulmus davidiana var. japonica. J Enzyme Inhib Med Chem. 2021;36(1):1049–1055.
   PubMed Web of Science ®Google Scholar
• Jang M, Park R, Park Y-I, Cha Y-E, Yamamoto A, Lee JI, Park J. EGCC, a green tea polyphenol, inhibits human coronavirus replication in vitro. Biochem Biophys Res Commun. 2021;547:23–28.
   PubMed Web of Science ®Google Scholar
• Ryu YB, Kim JH, Park S-J, Chang JS, Rho M-C, Bae KH, Park KH, Lee WS. Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorg Med Chem Lett. 2010;20(3):971–974.
   PubMed Web of Science ®Google Scholar
• Gafner S, Bergeron C, Villinski JR, Godejohann M, Kessler P, Cardellina JH, Ferreira D, Feghali K, Grenier D. Isoflavonoids and coumarins from Glycyrrhiza uralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification. J Nat Prod. 2011;74(12):2514–2519.
   PubMed Web of Science ®Google Scholar
• Seon MR, Lim SS, Choi HJ, Park SY, Cho HJ, Kim J-K, Kim J, Kwon DY, Yoon Park JH. Isoangustone A present in hexane/ethanol extract of Glycyrrhiza uralensis induces apoptosis in DU145 human prostate cancer cells via the activation of DR4 and intrinsic apoptosis pathway. Mol Nutr Food Res. 2010;54(9):1329–1339.
   PubMed Web of Science ®Google Scholar
• Yang H, Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol. 2021;19(11):685–700.
   PubMed Web of Science ®Google Scholar
• Kumari M, Lu R-M, Li M-C, Huang J-L, Hsu F-F, Ko S-H, Ke F-Y, Su S-C, Liang K-H, Yuan JP-Y, Chiang H-L, Sun C-P, Lee I-J, Li W-S, Hsieh H-P, Tao M-H, Wu H-C. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. J Biomed Sci. 2022;29(1):68.
   PubMed Web of Science ®Google Scholar
• Bachar SC, Mazumder K, Bachar R. Aktar A, Al Mahtab M. A review of medicinal plants with antiviral activity available in Bangladesh and mechanistic insight into their bioactive metabolites on SARS-CoV-2, HIV and HBV. Frontiers Pharm. 2021;122:732891.
   Google Scholar
• Diomede L, Beeg M, Gamba A, Fumagalli O, Gobbi M, Salmona M. Can antiviral activity of licorice help fight COVID-19 infection? Biomolecules. 2021;11:855.
   PubMed Web of Science ®Google Scholar
• de Vivo M, Masett M, Bottegoni G, Cavalli A. Role of molecular dynamics and related methods in drug discovery. J Med Chem. 2016;59(9):4035–4061.
   PubMed Web of Science ®Google Scholar
• Milani M, Donalisio M, Bonotto RM, Schneider E, Arduino I, Boni F, Lembo D, Marcello A, Mastrangelo E. Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. Antiviral Res. 2021;189:105055.
   PubMed Web of Science ®Google Scholar